Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Echinococcus granulosus | mitogen activated protein kinase 3 | 0.0506 | 0.5 | 0.5 |
Leishmania major | mitogen activated protein kinase 4, putative;with=GeneDB:LmxM19.1440 | 0.0506 | 0.5 | 0.5 |
Trichomonas vaginalis | CMGC family protein kinase | 0.0506 | 0.5 | 0.5 |
Trichomonas vaginalis | CMGC family protein kinase | 0.0506 | 0.5 | 0.5 |
Echinococcus granulosus | mitogen activated protein kinase | 0.0506 | 0.5 | 0.5 |
Trypanosoma brucei | protein kinase, putative | 0.0506 | 0.5 | 0.5 |
Trypanosoma cruzi | mitogen activated protein kinase 4, putative | 0.0506 | 0.5 | 0.5 |
Trichomonas vaginalis | CMGC family protein kinase | 0.0506 | 0.5 | 0.5 |
Echinococcus multilocularis | mitogen activated protein kinase | 0.0506 | 0.5 | 0.5 |
Schistosoma mansoni | serine/threonine protein kinase | 0.0506 | 0.5 | 0.5 |
Trichomonas vaginalis | CMGC family protein kinase | 0.0506 | 0.5 | 0.5 |
Trypanosoma cruzi | mitogen-activated protein kinase 11, putative | 0.0506 | 0.5 | 0.5 |
Trypanosoma brucei | mitogen activated protein kinase 4, putative | 0.0506 | 0.5 | 0.5 |
Echinococcus multilocularis | mitogen activated protein kinase 3 | 0.0506 | 0.5 | 0.5 |
Giardia lamblia | Kinase, CMGC MAPK | 0.0506 | 0.5 | 0.5 |
Toxoplasma gondii | CMGC kinase, MAPK family (ERK) MAPK-1 | 0.0506 | 0.5 | 0.5 |
Loa Loa (eye worm) | CMGC/MAPK/ERK1 protein kinase | 0.0506 | 0.5 | 0.5 |
Trypanosoma cruzi | mitogen activated protein kinase 2, putative | 0.0506 | 0.5 | 0.5 |
Leishmania major | mitogen activated protein kinase, putative,map kinase, putative | 0.0506 | 0.5 | 0.5 |
Trypanosoma cruzi | mitogen-activated protein kinase 11, putative | 0.0506 | 0.5 | 0.5 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
IC50 (functional) | = 6 ng ml-1 | In vitro antimalarial activity against chloroquine-resistant K1 clone of Plasmodium falciparum | ChEMBL. | 15050646 |
IC50 (functional) | = 20 ng ml-1 | In vitro antimalarial activity against chloroquine-sensitive 3D7 clone of Plasmodium falciparum | ChEMBL. | 15050646 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.